Opendata, web and dolomites


A tissue-on-a-chip platform for systems-level studies of ALS pathology and drug screening

Total Cost €


EC-Contrib. €






 Als-on-a-chip project word cloud

Explore the words cloud of the Als-on-a-chip project. It provides you a very rough idea of what is the project "Als-on-a-chip" about.

inside    als    panels    world    despite    companies    neurons    intracellular    failures    description    ways    translate    inability    relocate    mice    interpreted    host    tenure    normal    collaborate    scaffold    nerve    pharmacology    disease    researcher    environment    faculty    drug    cell    differences    acquired    mechanistic    startup    diseases    outcomes    cultured    motor    platform    candidate    lateral    analog    cells    opportunity    offers    fluorescent    quantified    3d    preclinical    throughput    treatments    thin    urgent    human    sclerosis    mit    communication    track    signaling    tissue    block    lab    pathology    amyotrophic    data    clinical    treatment    greece    stimuli    proteomics    trials    modifications    failed    attributed    hsod1g93a    complement    neurodegenerative    mouse    envisions    screening    people    leads    partly    porous    imaging    chip    neurobiology    suggest    tool    fatal    approximately    tools    appropriate    sme    biology    drugs    class    ecm    100000    physiology    translated    position    model   

Project "Als-on-a-chip" data sheet

The following table provides information about the project.


Organization address
address: N PLASTIRA STR 100
postcode: 70013

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Greece [EL]
 Project website
 Total cost 164˙653 €
 EC max contribution 164˙653 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-RI
 Starting year 2015
 Duration (year-month-day) from 2015-09-30   to  2017-09-29


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease, which affects approximately 2 per 100000 people. Currently, there is no ALS treatment. The main tool for preclinical ALS studies is the hSOD1G93A mouse. However, despite promising results in this model, all candidate drugs failed in clinical trials. These failures have been partly attributed to differences in the physiology of human and mice nerve cells, and the inability of the established drug design approach to block ALS pathology. There is urgent need for new tools that will complement this mouse model, improve understanding of ALS pathology, and suggest better leads for clinical trials. The objective of the proposed study is to develop a tissue-on-a-chip platform for systems-level studies of ALS pathology and drug screening. The system is built around a novel thin porous scaffold, where systems of normal or ALS-type mouse and human motor neurons will be cultured inside an appropriate 3D ECM analog, and their response (intracellular signaling, cell processes, cell-cell communication) to stimuli panels in the presence of drugs will be quantified via high-throughput proteomics and fluorescent imaging. Acquired data will be interpreted by modifications of state-of-the-art system biology tools. The outcomes of the proposed research can lead to new ALS treatments by identifying new drug targets (via mechanistic description of ALS pathology), and by developing better ways to evaluate candidate drugs before clinical trials (via comparing drug response in human and mouse cells). Results can be translated to other neurodegenerative diseases. Finally, the proposal offers an opportunity to a promising researcher to relocate from MIT to Greece, collaborate with a leading neurobiology lab in a world-class environment and a systems pharmacology SME, and translate his research via two startup companies. The host envisions the opportunity for a tenure-track faculty position for the experienced researcher.


year authors and title journal last update
List of publications.
2017 A. Gkousioudi, D. S. Tzeranis, G. P. Kanakaris, M. Saloufas, L. G. Alexopoulos
Quantifying Cartilage Biomechanical Properties Using a Linearized Frequency-Domain Method
published pages: 2061-2074, ISSN: 0090-6964, DOI: 10.1007/s10439-017-1861-1
Annals of Biomedical Engineering 45/9 2019-06-14
2017 Ioannis V. Yannas, Dimitrios S. Tzeranis, Peter T. C. So
Regeneration of injured skin and peripheral nerves requires control of wound contraction, not scar formation
published pages: 177-191, ISSN: 1067-1927, DOI: 10.1111/wrr.12516
Wound Repair and Regeneration 25/2 2019-06-14

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALS-ON-A-CHIP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ALS-ON-A-CHIP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

POMOC (2019)

Charles IV and the power of marvellous objects

Read More  

TIPTOP (2019)

Tensoring Positive Maps on Operator Structures

Read More  

MingleIFT (2020)

Multi-color and single-molecule fluorescence imaging of intraflagellar transport in the phasmid chemosensory cilia of C. Elegans

Read More